Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gestrinone versus mifepristone for emergency contraception
ISRCTN87842530Phase 3Completed
- Sponsor
- World Health Organization
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Gestrinone and mifepristone in contraception (2 arms), sponsored by World Health Organization. Primary endpoint: Pregnancy rate. Started Nov 2002; status: completed.
02
Drugs
Gestrinonemifepristone
03
Conditions
contraception
Beyond the preview
Go deeper on ISRCTN87842530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87842530.